Preserving renal function: gliflozins, GLP1 agonists, and antialdosterones
{{output}}
For a long time, a prognostic and therapeutic fatalism accompanied even the most motivated clinicians when they had to deal with a progressive decline in renal function; the modest successes were nullified by an increasingly aggressive syndrome whose therapy h... ...